AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06772480 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Argon Plasma Coagulation
Description: Patients will undergo APC treatment every 2-3 weeks initially, followed by maintenance sessions every three months as required.
Study NCT06773767 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 150 mg trazodone hydrochloride
Description: To compare the bioavailability of 150 mg trazodone hydrochloride tablets (new polymer) vs. 150 mg trazodone hydrochloride Contramid® tablets at steady-state.
Study NCT06773767 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 300 mg trazodone hydrochloride
Description: To compare the bioavailability of 300 mg trazodone hydrochloride tablets (new polymer) vs. 300 mg trazodone hydrochloride Contramid® tablets at steady-state
Study NCT06770569 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS-3802
Description: HRS-3802
Study NCT06770855 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Total consolidative MPDT
Description: After stopping systemic anti-cancer therapy for metastatic RCC, participant will receive one or more of the following: surgery (e.g. nephrectomy, metastasectomy, lymph node dissection), percutaneous cryoablation and/or radiotherapy (SAbR or other definitive radiotherapy).
Study NCT06031389 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Henagliflozin
Description: On the basis of hypoglycemic therapy, the patients in the intervention group were given the drug treatment of hengglinide, once a day, 10mg or 5mg each time, taken in the morning, for 12 months.
Study NCT06031389 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: On the basis of basic treatment, patients in the blank control group were given starch tablets once a day, 10mg or 5mg each time, taken in the morning for 12 months.
Study NCT05762328 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Reminders to the assistant clinicians of the need to adhere to clinical guidelines regarding the duration of antibiotic treatment community-acquired pneumonia
Description: Automatic reminders through pop-up windows in the computerized prescription software, reminding the clinician responsible for each patient of the need to adhere to clinical guidelines regarding the duration of antibiotic treatment in patients with clinical stability
Study NCT06774599 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: music combined with lavender essential oil group
Description: listening of 30 mins ocean wave music, aromatherapy of lavender essential oil, and eye masks and earplugs.
Study NCT06775145 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HD-R_cDC+cTBS & sham-L_aDC+iTBS
Description: HD-tES inhibitory waveform (cDC+cTBS) applied to the right dorsolateral prefrontal cortex (DLPFC) for 10 minutes, followed by sham excitatory waveform (aDC+iTBS) stimulation applied to the left DLPFC for 10 minutes.
Study NCT06775145 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: sham-R_cDC+cTBS & HD-L_aDC+iTBS
Description: Sham inhibitory waveform (cDC+cTBS) stimulation applied to the right DLPFC for 10 minutes, followed by HD-tES excitatory waveform (aDC+iTBS) applied to the left DLPFC for 10 minutes.
Study NCT06299189 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MinADHD
Description: Guided self-help, 7 modules Interventions
Study NCT06775145 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HD-R_cDC+cTBS & HD-L_aDC+iTBS
Description: HD-tES inhibitory waveform (cDC+cTBS) applied to the right DLPFC for 10 minutes, followed by HD-tES excitatory waveform (aDC+iTBS) applied to the left DLPFC for 10 minutes.
Study NCT06775145 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham-R_cDC+cTBS & sham-L_aDC+iTBS
Description: Sham inhibitory waveform (cDC+cTBS) stimulation applied to the right DLPFC for 10 minutes, followed by sham excitatory waveform (aDC+iTBS) stimulation applied to the left DLPFC for 10 minutes.
Study NCT06774443 — intervention group
Intervention type: OTHER
Intervention: Neuropsychological assessment
Description: Neuropsychological assessment consisting of tests measuring social cognition and memory
Study NCT06771063 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: WXSH0102/placebo
Description: Administer WXSH0102 tablets/placebo orally.
Study NCT06771063 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: fluconazole capsules/placebo
Description: Administer fluconazole capsules/placebo orally
Study NCT06774807 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline/Placebo
Description: NaCl (9mg/ml)
Study NCT05429086 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remimazolam combined propofol
Description: Remimazolam combined propofol
Study NCT05429086 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Remimazolam
Description: remimazolam only
Study NCT05429086 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: propofol only
Study NCT06774807 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Agonist/Saline
Description: GLP-2(1-33)/Saline (9mg/ml)
Study NCT06774807 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Agonist/1Antagonist
Description: GLP-2 (1-33)/GLP-2(3-33) 1 nmol/kg/min
Study NCT06774807 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Agonist/4Antagonist
Description: GLP-2 (1-33)/GLP-2 (3-33) 4 nmol/kg/min
Study NCT06770686 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention Group
Description: A nursing care bundle will be applied to patients in the intervention group. The implementation status of the nursing interventions included in the care bundle for each patient will be observed by the researcher and recorded on the Care Bundle Observer Form. Recording of the applications performed on the monitoring form will be encouraged.
Study NCT06770686 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Group
Description: They will receive standard care
Study NCT06774664 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: SCTC21C
Description: Drug: SCTC21C Administered SC
Study NCT06774664 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SCTC21C
Description: Drug: SCTC21C Administered SC
Study NCT06773780 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: local infiltration
Description: The block procedure will be performed before the surgical procedure, following the induction of sedoanalgesia. Under sterile conditions, 30 mL of 0.25% bupivacaine will be administered to the targeted infiltration area. The local anesthetic will be specifically applied around the arterial and venous puncture sites.
Study NCT06773780 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: PENG
Description: With the patient in the supine position, a convex ultrasound (US) probe (4-8 MHz, Vivid Q) will be covered with a sterile sheath. An 80-mm block needle (Braun 360°) will be used. The probe will be placed transversely over the anterior inferior iliac spine. Subsequently, the probe will be rotated 45 degrees to visualize the pubic ramus. Once the femoral artery, iliopubic eminence, and psoas muscle are identified under ultrasound guidance, the needle will be advanced using an in-plane technique and positioned between the pubic ramus and the psoas tendon. After confirming the block site with 5 mL of saline, 30 mL of 0.25% bupivacaine will be injected as the local anesthetic.
Study NCT06773780 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FİB
Description: The patient's legs will be positioned slightly externally rotated. A high-frequency ultrasound probe will be placed transversely along the inguinal ligament. Under ultrasound guidance, the femoral artery, iliopsoas muscle, and fascia iliaca will be identified. The needle will be advanced parallel to the ultrasound probe using the in-plane technique and positioned beneath the fascia iliaca. After confirming negative aspiration, 30 mL of 0.25% bupivacaine will be injected, and the spread of the solution beneath the fascia iliaca will be verified using ultrasound.
Study NCT06770465 — intervention group
Intervention type: DRUG
Intervention: Different categories of antibiotics
Description: Use of different categories of antibiotics during pregnancy, such as quinolones and macrolides.
Study NCT06772181 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cardio fitness, Yoga, Tai Chi, Qigong, Dance Cardio, Guided Meditation, Music Therapy
Description: Participate in the IM@Home program delivered via Zoom
Study NCT06772181 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Medical Device Usage and Evaluation
Description: Wear a FitBit activity tracker
Study NCT06772181 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Complete PRO surveys
Study NCT06772350 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: examinations
Description: Echo-Doppler and blood samples
Study NCT06126991 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetirizine
Description: Oral administration of cetirizine at 10mg once daily will be used.
Study NCT06126991 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam and Fentanyl
Description: Midazolam 50mg + fentanyl 300ug micro pump push will be used with a starting dose of 5ml/hour, adjusted according to the patient's level of sedation. The patient's RASS score will be maintained between -1-0 and the drug will be suspended with a blood pressure below 90/60mmHg.
Study NCT06126991 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Midazolam and Fentanyl
Description: Midazolam 50mg + fentanyl 300ug micro pump push will be used with a starting dose of 5ml/hour, adjusted according to the patient's level of sedation. The patient's RASS score will be maintained between -1-0 and the drug will be suspended with a blood pressure below 90/60mmHg.
Study NCT05756725 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Practice-Level Implementation Strategies
Description: The intervention is implementation of new population health management tools that may better leverage patient navigation and other staff resources to ensure timely abnormal follow up of breast and colorectal cancer screening. The research team will work with CHCs to select implementation strategies that will best facilitate integration of the new tools into practice. The team will use electronic health record data (analyzed at the population level) to determine the impact of the new tools on screening outcomes and qualitative data from up to 3 staff and 2 patients per CHC to evaluate integration of the tools into practice.
Study NCT04861337 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remimazolam
Description: Remimazolam is infused at a rate of 0.25 mg/kg/h from end of anesthesia induction until 15 minutes before the end of surgery.
Study NCT04861337 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Normal saline is infused at a rate same as in the remimazolam group from end of anesthesia induction until 15 minutes before the end of surgery.
Study NCT05670626 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Refractive Surgery
Description: Phakic implantable contact lens ( ICL)
Study NCT06774651 — intervention group
Intervention type: PROCEDURE
Intervention: Procedure: Corneal lenticule extraction for advanced refractive correction (CLEAR)
Description: Routinely conducted procedure using FEMTO LDV Z8 laser system for correction of Myopia.
Study NCT06774651 — intervention group
Intervention type: PROCEDURE
Intervention: Procedure: Small Incision Lenticule Extraction (SMILE)
Description: Routinely conducted procedure using VisuMax laser system for correction of Myopia.
Study NCT06774105 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Static Stretching
Description: The protocol consisted in 2 sessions per week, each comprising 8 exercises of static stretching targeting all major muscle groups: 1) Hamstrings, 2) Knee Extensors, 3) Dorsal muscles, 4) Pectoralis muscles, 5) Elbow Flexors (biceps), 6) Elbow Extensors (triceps), 7) Adductors, and one day 8a) Spine Extensors while the second 8b) Spine Flexors. Each exercise involved 4 sets of 30 seconds of SS and 30 seconds of rest.
Study NCT06770920 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: use of an observer tool when not role-playing
Description: Observers will use an observer tool (based on technical skills and specifically related to airway management during BLS) when they will be not role role-playing.
Study NCT06773091 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: NK042
Description: NK042 is an allogeneic, off-the-shelf cellular therapy derived from healthy donors and enriched with NKR+ NK cells.
Study NCT06773091 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine (FLU)
Description: Fludarabine (FLU) is administered as a lymphodepletion regimen prior to NK042 infusion.
Study NCT05374707 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MOTIVATIONAL INTERVIEWING
Description: Motivational interviewing is a form of interview conducted with a patient-centered approach in order to enable people to discover and solve the obstacles to behavior change.
Study NCT06773091 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (CTX)
Description: Cyclophosphamide (CTX) is administered as a lymphodepletion regimen prior to NK042 infusion.
Study NCT05073055 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: İnguinal Hernia Repair
Description: After hemodynamic stability, the patient was placed in the lateral position and infiltration anesthesia with 2% lidocaine was applied. Following aseptic preparation of the skin and probe, a medium-frequency curvey USG transducer was first placed in the midline to visualize the transverse projection of the first lumbar (L1) vertebra, then moved 2.5 cm laterally in the parasagittal plane, after imaging the transverse process, in-plane spreading was injected. Hydrodissection was achieved on the TP of L1 by using a 5 cm, 21G peripheral nerve block needle just below the erector spina muscle with real-time imaging of the substance. Afterwards, a unilateral injection of 15 ml at T12 and L1 levels was applied to each segment with the needle directed at two different angles from the same insertion point.
Study NCT05422131 — intervention group
Intervention type: DEVICE
Intervention: MyCare Insite Clozapine Test
Description: The MyCare Insite Clozapine Test is a 2 reagent system designed to evaluate the level of antipsychotic drug clozapine in a patients blood using the near patient device the MyCare Insite Analyser.
Study NCT04918342 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multidimensional Exercise Program
Description: The multidirectional exercise program will include cardiovascular training, strengthening, balance training, and flexibility training. This will be delivered 2 times per week for 8 weeks using telehealth and will be delivered by a physical therapist. The exercises will be modified to meet the participants needs. Intensity of exercise interventions will be monitored through patient self report and use of continuous heart rate monitoring.
Study NCT04918342 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Multidimensional Exercise Program
Description: The multidirectional exercise program will include cardiovascular training, strengthening, balance training, and flexibility training. This will be delivered 2 times per week for 8 weeks using telehealth and will be delivered by a physical therapist. The exercises will be modified to meet the participants needs. Intensity of exercise interventions will be monitored through patient self report and use of continuous heart rate monitoring.
Study NCT04535219 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: 60 minutes of moderate-intensity treadmill exercise (70% of maximal heart rate determined from the maximal graded exercise test)
Study NCT04535219 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Supervised Total Sleep Deprivation
Description: Laboratory-monitored total sleep deprivation
Study NCT06770985 — intervention group
Intervention type: OTHER
Intervention: Artificial Intelligence
Description: Ollama (Ollama., 2024, https://ollama.ai/) artificial intelligence program and PYTHON 3 Programming Language and open source libraries will be used for the necessary algorithms for data review and analysis. In case of deficiencies in the data of the patients; the missing data will be edited using Data Imputation techniques. Number of files to be reviewed and/or date range to be covered: Patients who underwent lung resection between January 2023 and October 2024 will be included. An estimated 2000 files are planned to be scanned.
Study NCT06773988 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Monitoring of NIV at home
Description: Monitoring of NIV at home
Study NCT06772597 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Setmelanotide
Description: Setmelanotide (daily subcutaneous injection)
Study NCT05853055 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Respiratory training
Description: Respiratory training will be included in the rehabilitation program of a subgroup of post-COVID-19 patients. The intervention group will train twice daily for the length of their rehabilitation stay using an incentive spirometer (Voldyne 5000 R, Sherwood Medical, St. Louis, USA). Subjects will be instructed to first completely exhale slowly. Then inspire slowly up to 70% of their vital capacity, producing a constant flow controlled via feedback from the device. This procedure will be repeated every 30 s (paced by a metronome) for 15 min. The training will be conducted twice a day, resulting in a total of 60 inspirations per day.
Study NCT05665049 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social Transfer
Description: Social transfers are defined as a cash or in-kind transfer. Using results from a qualitative study, we identified the following culturally grounded social transfer options that is responsive to the identified needs of new mothers. Based on the monthly Lao PDR minimum wage and an estimated 15 full working days needed to exclusively breastfeed over a 6-month period, a social transfer of approximately $75 would fairly subsidize women's breastfeeding efforts. Therefore all social transfer options equate to approximately 75 USD. The options include: diapers, child developmental toys, cash, or a combination of these.
Study NCT04557384 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ramucirumab
Description: Administered SC
Study NCT06300515 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control Group (Active Comparator)
Description: During the intervention phase (hospitalization for HSCT and subsequent 8-week outpatient phase following discharge), the control group will participate in a Health Counseling Program (1 time/week) on aspects related to a healthy lifestyle such as reducing sedentary lifestyle, acquiring healthy nutritional habits, the importance sleep, screen use, and how to address barriers related to clinical status. We will adapt the program to the needs and timing of the patient's treatment, providing the content in one session/week orally (e.g. using presentations) and in writing (e.g. through brochures).
Study NCT06300515 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention Group
Description: Same as Control Group + exercise program as described below:~Same as Control Group + exercise program as described below:~Hospital ward (during HSCT); and Hospital Gym or online (patients' home) during the outpatient phase. Frequency: 3-5 days/week. Session duration: 30 to 55-60 minutes Aerobic training (5-25 minutes): bicycling, crank-ergometry, circuit-style exercises, and games. Muscle strength training (10-20 minutes): large muscle group exercises (upper/lower limb + trunk exercises) performed as a circuit using body weight or against resistance (against gravity and with body weight, elastic bands, dumbbells, weighted vests, machines), with a wide range of joint mobility and at submaximal/maximum voluntary speed. Inspiratory muscle training will also be performed (5 min daily, using a specific device that creates resistance against inspiration).
Study NCT02312570 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PRP Concepts Fibrin Bio-Matrix
Description: Administration of PRP Concepts Fibrin Bio-Matrix to wound in addition to usual and customary care
Study NCT02312570 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual and Customary Practice
Description: Ussual and customary care of non-healing pressure wounds
Study NCT02312570 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual and Customary Practice
Description: Ussual and customary care of non-healing pressure wounds
Study NCT05858190 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Parallel Assignment
Description: intervention group: treated with drug eluting balloon（paclitaxel-coated balloon； Orchid, Acotec Scientific Holdings Limited, Beijing, China)； control group :treated with plain old balloon
Study NCT05858190 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Parallel Assignment
Description: intervention group: treated with drug eluting balloon（paclitaxel-coated balloon； Orchid, Acotec Scientific Holdings Limited, Beijing, China)； control group :treated with plain old balloon
Study NCT06236347 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smoking cessation e-visit
Description: Electronic visits (e-visits) for smoking cessation